Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

Methods for measuring proteasome activity: current limitations and future developments.

A Liggett1, L J Crawford, B Walker

  • 1Centre for Cancer Research and Cell Biology, Queen's University, Belfast, Belfast, UK.

Leukemia Research
|August 3, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovation and enculturation in child communication: a cross-sectional study.

Evolutionary human sciences·2023
Same author

Adult Asthma Diagnosis: Physician Reported Challenges in Alberta-Based Primary Care Practices.

SAGE open nursing·2021
Same author

Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study.

Allergologia et immunopathologia·2019
Same author

Hospitalizations for asthma exacerbation in Chilean children: A multicenter observational study.

Allergologia et immunopathologia·2018
Same author

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

The European respiratory journal·2017
Same author

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.

Clinical pharmacology and therapeutics·2017
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

This review evaluates methods for profiling proteasome activity, crucial for developing targeted therapies like proteasome inhibitors for Multiple Myeloma. Advances in these techniques will accelerate drug development for proteasome-related diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The proteasome is a validated therapeutic target, particularly for Multiple Myeloma treatment using proteasome inhibitors.
  • Various methods exist to profile proteasome activity, including fluorogenic peptide substrates, bioluminescent imaging, immunological methods, and fluorescent probes.

Purpose of the Study:

  • To critically evaluate current methods for profiling proteasome activity.
  • To assess the suitability of these methods for translational studies.
  • To guide future research in proteasome-related pathologies and drug development.

Main Methods:

  • Review of existing literature on proteasome activity profiling techniques.
  • Comparative analysis of fluorogenic peptide substrates, bioluminescent imaging, immunological methods, and fluorescent probes.

More Related Videos

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
09:45

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Published on: May 10, 2015

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
09:45

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Published on: May 10, 2015

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

  • Assessment of translational applicability of each method.

    • Main Results:

    • Fluorogenic peptide substrates are the current standard but have limitations.
    • Bioluminescent imaging, immunological methods, and fluorescent probes offer alternative or complementary approaches.
    • The choice of method depends on the specific application and translational goals.

    Conclusions:

    • Continued development of proteasome activity profiling techniques is essential.
    • Improved methods will accelerate research into proteasome-related diseases.
    • This will facilitate the development of more targeted and effective drug regimes.